At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Neurological Complications of COVID-19
In Brief
An observational study for SARS-CoV 2 and Neurologic Manifestations. Completed, enrolled 300 participants across 1 site.
Detailed Summary
This study is a prospective observational cohort study to document the prevalence and types of neurological manifestations among hospitalized patients with confirmed or suspected novel coronavirus infection (COVID-19).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV 2, Neurologic Manifestations
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartApr 2020
First PostedAug 2020
Primary CompletionMar 2021
Study CompletionMay 2021
TodayJul 2026
First PostedAug 3, 2020
Enrollment StartApr 13, 2020
Primary CompletionMar 31, 2021
Study CompletionMay 30, 2021
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 5.9 years ago